EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION

Show other versions (1)

<p>History of thrombolytic therapy is shortly reflected, main trials of various thrombolytics in acute ST-segment elevation myocardial infarction (STEMI) are analyzed. Perspectives of modern thrombolytic therapy in patients with STEMI are discussed.</p>

Bibliographic Details
Main Authors:	P. G. Kesov, O. M. Reytblat, Z. M. Safiullina, S. V. Shalaev
Format:	Article
Language:	English
Published:	Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:	Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:	тромболитическая терапия инфаркт миокарда с подъёмом сегмента ST
Online Access:	http://www.rpcardio.ru/jour/article/view/222

Similar Items

CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES
by: O. V. Reshetko, et al.
Published: (2016-01-01)

Use of pharmacoinvasive approach to the treatment of patients with ST segment elevation acute coronary syndrome: state of the problem
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL
by: J. L. Mega, et al.
Published: (2015-09-01)

Thrombolytic therapy and cardiac free wall rupture in patients with acute myocardial infarction
by: E M Zeltyn-Abramov, et al.
Published: (2009-03-01)

THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION
by: D. P. Sementsov
Published: (2015-12-01)

THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION)
by: V. A. Sulimov
Published: (2015-09-01)

RESULTS OF TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DATA OF A RETROSPECTIVE, SINGLE-CENTER STUDY (IN-HOSPITAL PERIOD)
by: D. B. Nemick, et al.
Published: (2015-12-01)

Coronary microvascular obstruction (the no-reflow phenomenon) during percutaneous coronary interventions in patients with myocardial infarction
by: A. A. Frolov, et al.
Published: (2020-04-01)

MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH PERSISTENT ST-SEGMENT ELEVATION
by: Frans Van de Werf, et al.
Published: (2016-01-01)

COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE
by: V. V. Omel'yanovskiy, et al.
Published: (2016-01-01)

CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE
by: K. A. Kireev, et al.
Published: (2015-09-01)

NONINVASIVE EVALUATION OF FIBRINOLYTIC TREATMENT EFFICACY IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION
by: I. I. Shevchenko
Published: (2016-01-01)

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION
by: P. G. Kesov, et al.
Published: (2015-09-01)

Тромболизис – чрескожное коронарное вмешательство при остром коронарном синдроме с подъемом сегмента ST: смена акцентов
Published: (2016-12-01)

Outcomes of coronary artery bypass grafting in patients with high-risk non-ST-segment elevation acute coronary syndrome within the first 24 hours of admission
by: A. B. Nishonov, et al.
Published: (2020-07-01)

RELEVANCE AND ROLE OF RISK FACTORS IN THE DEVELOPMENT OF MYOCARDIAL INFARCTION
by: Андрей Георгиевич Петров, et al.
Published: (2021-06-01)

TYPE 2 MYOCARDIAL INFARCTION: CLINICAL AND DEMOGRAPHIC FEATURES, LABORATORY AND INSTRUMENTAL ASSOCIATIONS
by: H T Hoang, et al.
Published: (2018-12-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

GENETIC ASPECTS OF MYOCARDIAL INFARCTION: PROBLEMS AND PERSPECTIVES
by: P. A. Shesternya, et al.
Published: (2012-02-01)

ELECTROCARDIOGRAM ST SEGMENT DEPRESSION AND ELEVATION IN STRESS-TESTING
by: D. A. Kuzhel, et al.
Published: (2015-09-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

Cardioprotective effect of lithium chloride on a rat model of myocardial infarction
by: O. A. Grebenchikov, et al.
Published: (2019-10-01)

CARDIAC RUPTURE IN MYOCARDIAL INFARCTION: INCIDENCE AND PREDISPOSING FACTORS (15 YEAR FOLLOW-UP)
by: V. A. Shulman, et al.
Published: (2015-12-01)

COMPLIANCE RESEARCH CONCEPTS AS A BASIS FOR UNDERSTANDING ADHERENCE TO TREATMENT IN PATIENTS WITH MYOCARDIAL INFARCTION
by: Андрей Георгиевич Петров, et al.
Published: (2021-06-01)

CONCEPT OF MEDICAL AND PHARMACEUTICAL CARE FOR MYOCARDIAL INFARCTION AS A PROSPECTIVE FORM OF SERVICE TO THE POPULATION
by: Андрей Георгиевич Петров, et al.
Published: (2021-04-01)

Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders
by: B. U. Mardanov, et al.
Published: (2015-11-01)

Primenenie Trimetazidina? pri ishemicheskoy bolezni serdtsa v sochetanii s sakharnym diabetom
by: Yu A Fedotkina, et al.
Published: (2002-06-01)

Primenenie Sibutramina (meridia) v terapii bol'nykh sakharnym diabetom tipa 2
by: S A Butrova
Published: (2002-06-01)

Sudden cardiac death as an onset of myocardial infarction
by: M N Sadykov, et al.
Published: (2018-04-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE
by: P. V. Dolotovskaya, et al.
Published: (2015-09-01)

ATRIAL FIBRILLATION ASSOCIATED WITH MYOCARDIAL INFARCTION OF DIFFERENT LOCALIZATIONS
by: R. Bhattarai, et al.
Published: (2015-09-01)

CLINICAL AND FUNCTIONAL CHARACTERISTICS OF PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION DEPENDING ON THE METABOLIC SYNDROME PRESENCE OR ABSENCE
by: R. D. Kurbanov, et al.
Published: (2015-09-01)

DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS. PART II
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS (PART I)
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

PREDICTORS OF ADVERSE LEFT VENTRICULAR REMODELING IN PATIENTS AFTER MYOCARDIAL INFARCTION
by: E S Zharikova, et al.
Published: (2017-12-01)

RELATION OF PRO-INFLAMMATORY MARKERS IN MEN AND WOMEN WITH ONE YEAR OUTCOMES AFTER MYOCARDIAL INFARCTION
by: E. V. Tavlueva, et al.
Published: (2015-10-01)

ASSESSMENT OF CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH FIVE YEAR HISTORY OF MYOCARDIAL INFARCTION DEPENDING ON THE STATIN THERAPY COMPLIANCE
by: A. I. Chesnikova, et al.
Published: (2015-12-01)

ASSESSMENT OF SYSTEMIC INFLAMMATORY REACTION IN ACUTE MYOCARDIAL INFARCTION: STATUS UPDATE ON THE PROBLEM
by: M. A Kachkovsky, et al.
Published: (2015-09-01)